Non-bullous Impetigo
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo (NCT01803035) | Lytix Biopharma AS | 2013-02-01 |
Track Non-bullous Impetigo automatically
Every clearance here is in the API, with alerts when new ones post.